| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.06 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.094 | 0.06 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.094 | 0.06 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |